ALDOs as modifiers of the IGF pathway and methods of use

Details ALDOs as modifiers of the IGF pathway and methods of use ALDOs as modifiers of the IGF pathway and methods of use

2011-04-19

2011-04-19

Saidha, Tekchand (Department: 1652)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

C435S021000, C435S006120, C435S007800, C435S018000, C435S007100, C536S023200

Reexamination Certificate

active

07927872

ABSTRACT:
Human ALDO genes are identified as modulators of the IGF pathway, and thus are therapeutic targets for disorders associated with defective IGF function. Methods for identifying modulators of IGF, comprising screening for agents that modulate the activity of ALDO are provided.

REFERENCES:
patent: 7414119 (2008-08-01), Greenberg et al.
patent: 2004/0248142 (2004-12-01), Kinoshita et al.
patent: 2004 105013 (2004-04-01), None
patent: WO 02/077176 (2002-10-01), None
patent: WO 03/010336 (2003-02-01), None
patent: WO 03/100008 (2003-12-01), None
Song H. et al.: “Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 10, No. 4, Feb. 15, 2004, pp. 509-513.
Gure et al.: “Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene 1ocus on chromosome 3p21.3.” Cancer research, American Association for Cancer Research, Baltimore, MD, US, vol. 58, Mar. 1, 1998, pp. 1034-1041.
Patrick H. Maxwell et al.: “Activation of the HIF pathway in cancer,” Current Opinion in Genetics and Development, vol. 11, No. 3, Jun. 2001, pp. 293-299.
Moorehead, et al., “Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma.”, Oncogene, 2003, vol. 22, pp. 583-587.

Affiliated with

Also associated with

Rating

ALDOs as modifiers of the IGF pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with ALDOs as modifiers of the IGF pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ALDOs as modifiers of the IGF pathway and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2718406